BMEA vs. LAZR
BMEA (Biomea Fusion, Inc.) and LAZR (Luminar Technologies, Inc.) are both stocks. BMEA operates in Biotechnology (Healthcare), while LAZR operates in Software - Application (Technology). Over the past 5 years, BMEA returned -40.81%/yr vs -77.92%/yr for LAZR. At a 0.19 correlation, their price movements are largely independent.
Performance
BMEA vs. LAZR - Performance Comparison
Loading charts...
Returns By Period
BMEA
- 1D
- 5.38%
- 1M
- -9.87%
- YTD
- 10.48%
- 6M
- 15.13%
- 1Y
- -52.10%
- 3Y*
- -66.83%
- 5Y*
- -40.81%
- 10Y*
- —
LAZR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- -81.71%
- 1Y
- -94.51%
- 3Y*
- -87.70%
- 5Y*
- -77.92%
- 10Y*
- —
BMEA vs. LAZR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BMEA Biomea Fusion, Inc. | 10.48% | -68.04% | -73.28% | 72.24% | 13.15% | -59.95% |
LAZR Luminar Technologies, Inc. | 0.00% | -96.50% | -89.36% | -31.92% | -70.73% | -4.30% |
Correlation
The correlation between BMEA and LAZR is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Apr 19, 2021 | 0.19 |
Fundamentals
BMEA:
-$0.58
LAZR:
-$3.95
BMEA:
$0.00
LAZR:
$75.75M
BMEA:
-$947.00K
LAZR:
-$16.13M
BMEA:
-$60.67M
LAZR:
-$161.26M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMEA vs. LAZR — Risk / Return Rank
BMEA
LAZR
BMEA vs. LAZR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Biomea Fusion, Inc. (BMEA) and Luminar Technologies, Inc. (LAZR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BMEA | LAZR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.11 | ||
| Sortino ratioReturn per unit of downside risk | +0.58 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 0.84 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | -0.78 | -1.02 | +0.24 |
| Martin ratioReturn relative to average drawdown | -1.11 | -1.38 | +0.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BMEA | LAZR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.53 | -0.41 | -0.11 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.37 | -0.60 | +0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.36 | -0.53 | +0.16 |
Drawdowns
BMEA vs. LAZR - Drawdown Comparison
The maximum BMEA drawdown since its inception was -97.71%, roughly equal to the maximum LAZR drawdown of -99.97%. Use the drawdown chart below to compare losses from any high point for BMEA and LAZR.
Loading charts...
Drawdown Indicators
| BMEA | LAZR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.71% | -99.97% | +2.26% |
Max Drawdown (1Y)Largest decline over 1 year | -66.99% | -95.02% | +28.03% |
Max Drawdown (3Y)Largest decline over 3 years | -97.71% | -99.85% | +2.14% |
Max Drawdown (5Y)Largest decline over 5 years | -97.71% | -99.95% | +2.24% |
Current DrawdownCurrent decline from peak | -96.72% | -99.97% | +3.25% |
Average DrawdownAverage peak-to-trough decline | -66.74% | -62.81% | -3.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.00% | 69.84% | -22.84% |
Volatility
BMEA vs. LAZR - Volatility Comparison
Biomea Fusion, Inc. (BMEA) has a higher volatility of 20.06% compared to Luminar Technologies, Inc. (LAZR) at 0.00%. This indicates that BMEA's price experiences larger fluctuations and is considered to be riskier than LAZR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BMEA | LAZR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.06% | 0.00% | +20.06% |
Volatility (6M)Calculated over the trailing 6-month period | 64.42% | 192.18% | -127.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.31% | 234.15% | -133.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 110.84% | 131.57% | -20.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 109.67% | 115.80% | -6.13% |
Dividends
BMEA vs. LAZR - Dividend Comparison
Neither BMEA nor LAZR has paid dividends to shareholders.
Financials
BMEA vs. LAZR - Financials Comparison
This section allows you to compare key financial metrics between Biomea Fusion, Inc. and Luminar Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BMEA and LAZR have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BMEA has higher volatility (20.06%) compared to LAZR (0.00%). In terms of maximum drawdown, BMEA dropped -97.71% vs LAZR's -99.97%.
LAZR currently has the higher Sharpe Ratio (-0.41 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BMEA and LAZR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer